The new oral therapy demonstrates superior lesion healing for complex patients who have few current treatment options.
Three-phase treatment offers patients with HSV infections an alternative to perpetual antiviral management ROATAN, BAY ...
Herpes is one of the most common viral infections in the world, yet it remains widely misunderstood. Caused by the herpes ...
A phase 3 trial finds pritelivir significantly improves cure rates for immunocompromised individuals with refractory HSV infections.
Genital herpes infections are very common. There are 42 million new infections each year — that averages out to one new person infected each second. While treatments can help with symptoms, there's no ...
Clinical Trials Arena on MSN
AiCuris reports positive Phase III pritelivir results for HSV patients
The trial enrolled and treated 101 immunocompromised patients with refractory or resistant HSV infection.
Add Yahoo as a preferred source to see more of our stories on Google. man holding a hand ove rhis mouth A new study has confirmed genital herpes is the most common sexually transmitted infection (STI) ...
Researchers at the University of Jyväskylä (Finland), in cooperation with national and international research groups, have ...
The US Preventive Services Task Force (USPSTF) has released new recommendations advising against screening for genital herpes simplex virus (HSV) in asymptomatic adolescents and adults, including ...
Around 846 million people aged between 15 and 49 are living with genital herpes infections – more than 1 in 5 of this age-group globally – according to new estimates released today. At least 1 person ...
People diagnosed with HSV-1 infection had a higher risk of a subsequent Alzheimer's diagnosis. Antiherpetic drugs reduced Alzheimer's risk in those diagnosed with HSV-1. The findings apply only to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results